This is a revision of application R01 HL074104-01 reviewed in February 2003. Accelerated decline in FEV1 predicts morbidity, mortality and functional limitation. Disproportionately low FEV1 is a cardinal sign of Chronic Obstructive Pulmonary Disease, a common, expensive, and serious disease. Studies relying on measured FEV1 take a long time and large numbers. If valid biomarkers were available, they could be used to efficiently screen potential therapies and identify persons at risk for the development of COPD. Our studies using cDNA microarray technology, have established associations between COPD and two chemokine receptors, CXCR-2 and CXCR-5 using cellular constituents of bronchoalveolar fluid in COPD patients. We propose to evaluate whether peripheral blood mononuclear cell expression of these and related biomarkers predict accelerated FEV1 decline in an established community-based cohort, the Health ABC study. Spirometry was performed on 2075 participants in Year 5 of the study. We propose to repeat spirometry in Years 8 and 10 of the study to test the hypotheses that: 1) peripheral blood mononuclear cell mRNA expression of CXCR-2, CXCR-5, IL-8 and IL- 6 will predict the accelerated decline in FEV1 over a five-year period in both those with airway obstruction and those without; and 2) serum levels of IL-8, IL-6, C-reactive protein will predict the accelerated decline in FEV1 over a five-year period in both those with airway obstruction and those without. COPD has increasingly been seen to be a systemic disease characterized by loss of lower extremity lean body mass, loss of strength, and poor endurance. These changes are important features of the diminished physical function seen with the disease. We suspect that some of the biomarkers associated with COPD may be as much related to changes in physical symptoms as to changes in pulmonary function. Therefore, we propose to test the additional hypothesis: 3) inflammatory biomarkers will predict the accelerated loss of lean body mass, loss of strength and loss of endurance over a 5- year period. Because this study is being done as an ancillary study to an established cohort in which many of the study measures either have or will be performed, these hypotheses can be tested in a cost-efficient manner.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL074104-03
Application #
7058293
Study Section
Epidemiology of Clinical Disorders and Aging Study Section (ECDA)
Program Officer
Croxton, Thomas
Project Start
2004-05-07
Project End
2008-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
3
Fiscal Year
2006
Total Cost
$517,740
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Urbinati, Fabrizia; Hargrove, Phillip W; Geiger, Sabine et al. (2015) Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells. Exp Hematol 43:346-351
Bentley, A R; Kritchevsky, S B; Harris, T B et al. (2012) Dietary antioxidants and forced expiratory volume in 1 s decline: the Health, Aging and Body Composition study. Eur Respir J 39:979-84
Aldrich, Melinda C; Kumar, Rajesh; Colangelo, Laura A et al. (2012) Genetic ancestry-smoking interactions and lung function in African Americans: a cohort study. PLoS One 7:e39541
Bentley, Amy R; Kritchevsky, Stephen B; Harris, Tamara B et al. (2012) Genetic variation in antioxidant enzymes and lung function. Free Radic Biol Med 52:1577-83
Georgiopoulou, Vasiliki V; Kalogeropoulos, Andreas P; Psaty, Bruce M et al. (2011) Lung function and risk for heart failure among older adults: the Health ABC Study. Am J Med 124:334-41
van den Borst, Bram; Koster, Annemarie; Yu, Binbing et al. (2011) Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax 66:961-9
Soler Artigas, MarĂ­a; Loth, Daan W; Wain, Louise V et al. (2011) Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 43:1082-90
Yende, Sachin; van der Poll, Tom; Lee, Minjae et al. (2010) The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax 65:870-7
Yende, Sachin; Angus, Derek C; Ding, Jingzhong et al. (2007) 4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia. Am J Respir Crit Care Med 176:1129-37
Yende, Sachin; Angus, Derek C; Ali, Ibrahim Sultan et al. (2007) Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc 55:518-25

Showing the most recent 10 out of 14 publications